Tesamorelin

Synthetic GHRH(1-44) analog studied in growth hormone secretion, visceral adipose signaling, IGF-1 modulation, and GH-axis research.

Growth Hormone Release Studies≥99% (HPLC verified) purity

$150.00

  • FormatLyophilized Powder / 20 mg
  • Storage-20°C for long-term stability

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that retains the full 44-amino-acid sequence of the naturally occurring human…

50 in stock

Tesamorelin$150.00
44Amino Acids
2010FDA Approval (Egrifta)
6Lots on Record
6Batch Assays
Overview

About Tesamorelin

Tesamorelin is a synthetic trans-3-hexenoic acid–modified analog of human growth hormone-releasing hormone (GHRH 1-44). Research has examined its interaction with GHRH receptors, endogenous growth hormone secretion, downstream IGF-1 signaling, visceral adipose tissue biology, body composition, and brain structure and function. Tesamorelin is also an approved pharmaceutical ingredient under the brand name Egrifta for a specific clinical indication; this research material is supplied for research use only.

Compound Information

Full Specification

Molecular FormulaC221H366N72O67S
Molecular Weight5135.89 g/mol
Purity≥99% (HPLC verified)
AppearanceWhite to off-white lyophilized powder
Storage-20°C for long-term stability
FormatLyophilized Powder / 20 mg
Molecular Structure

The Tesamorelin Molecule

An illustrative representation generated from the compound's molecular formula, alongside its logged molecular data. This figure is schematic — not a measured conformation.

Molecular Formula
C221H366N72O67S
Molecular Weight5135.89 g/mol
Sequence Length44 residues
CAS / ID218949-48-5
Physical FormWhite to off-white lyophilized powder
Documented Purity≥99% (HPLC verified)
Use ClassResearch Use Only
How It Works

How Tesamorelin Works

The pathways Tesamorelin acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.

Tesamorelin
GHRH-R Agonism
Lipolysis
Neuroprotection

Signalling pathways studied in preclinical models · illustrative

Growth Hormone Secretagogue

GHRH-R Agonism

Tesamorelin is a modified analog of human GHRH(1-44) that binds GHRH receptors and stimulates endogenous growth hormone secretion, with downstream IGF-1 production measured in research.

GHRH receptorGrowth hormoneIGF-1Pulsatile secretion

Visceral Adipose Signalling

Lipolysis

Tesamorelin is studied in relation to GH-mediated signaling in visceral adipose tissue, including hormone-sensitive lipase activity and free-fatty-acid release.

Visceral adiposeLipolysisHormone-sensitive lipaseGH signaling

Cognitive & Brain Research

Neuroprotection

Research has examined tesamorelin in relation to brain structure and function through the GH/IGF-1 axis, including regional gray matter volume and functional connectivity.

IGF-1Brain structureGray matterCognitive aging
Uses & Applications

What Tesamorelin Is Researched For

Metabolic Research

Visceral Fat & Body Composition

Studied in relation to GH-driven signaling in visceral adipose tissue and body-composition changes.

Cognitive Research

Brain Structure & Function

Studied through IGF-1 signaling in relation to regional brain volume, functional connectivity, and cognitive aging research.

Endocrinology

GH/IGF-1 Axis

Used as a research model for GHRH receptor pharmacology, growth hormone secretion, and downstream IGF-1 modulation.

Cardiometabolic Research

Lipid & Cardiovascular Markers

Research has examined triglycerides, non-HDL cholesterol, and carotid intima-media thickness in relation to GH-axis modulation.

Research Data

Study-Reported Magnitudes

Representative figures from published research; results vary by protocol.

GHRH Receptor Selectivity
15%
IGF-1 Level (fold change)
100%
Trunk Fat Area Reduction
18%
FAQ

Common Questions About Tesamorelin

What is tesamorelin and how is it different from growth hormone?+

Tesamorelin is a synthetic modified analog of human GHRH(1-44) that stimulates the pituitary to release endogenous growth hormone. It is studied through the GHRH/GH/IGF-1 axis rather than functioning as directly administered growth hormone.

Is tesamorelin FDA approved?+

The supplied source states that tesamorelin was FDA approved in 2010 under the brand name Egrifta for HIV-associated lipodystrophy. This research material is supplied for research use only and is not the approved pharmaceutical product.

How is tesamorelin characterised in visceral adipose research?+

Tesamorelin is studied in relation to GH-mediated lipolytic signaling in visceral adipose tissue, including hormone-sensitive lipase activity, free-fatty-acid release, and changes in visceral fat.

What is the cognitive research interest in tesamorelin?+

Research has examined tesamorelin through the GH/IGF-1 axis in relation to regional brain structure, gray matter volume, functional connectivity, and cognitive aging.

What are the safety considerations for tesamorelin?+

The supplied source does not provide a complete safety profile for this research material. Researchers should consult the relevant scientific literature and applicable institutional safety procedures before use.

How should research-grade tesamorelin be stored?+

The supplied specification recommends storage at -20°C for long-term stability.